0
Alzheimer’s disease and other forms of neurodegeneration can be identified using a combination of biomarkers in cerebrospinal fluid of living patients, researchers find.
Alzheimer’s disease and other forms of neurodegeneration can be identified using a combination of biomarkers in cerebrospinal fluid of living patients, researchers find.